Paper3105134
Overview of the development of Orthoclone OKT3: monoclonal antibody for therapeutic use in transplantation.
Goldstein G. Transplant Proc, 1987. Cited by 109 papers, by iCite.
Cite this record
ConductScience Library. Overview of the development of Orthoclone OKT3: monoclonal antibody for therapeutic use in transplantation. Papers, record 3105134. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3105134
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Overview of the development of Orthoclone OKT3: monoclonal antibody for therapeutic use in transplantation.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| Graft Rejection | Major topic |
| T-Lymphocytes | Major topic |
| Animals | |
| Antibodies, Anti-Idiotypic | |
| Antigens, Differentiation, T-Lymphocyte | |
| Antigens, Surface | |
| Heart Transplantation | |
| Humans | |
| Hybridomas | |
| Immunoglobulin Idiotypes | |
| Immunosuppression Therapy | |
| Kidney Transplantation | |
| Liver Transplantation | |
| Muromonab-CD3 |
Source PubMed
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 109 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40861455 | An explorable model of an adverse outcome pathway of cytokine release syndrome related to the administration of immunomodulatory biotherapeutics and cellular therapies. | Front Immunol | 2025 | https://conductscience.org/library/papers/40861455 | PubMed |
| 39312187 | Integrated Imaging Probe and Bispecific Antibody Development Enables In Vivo Targeting of Glypican-3-Expressing Hepatocellular Carcinoma. | Mol Cancer Ther | 2024 | https://conductscience.org/library/papers/39312187 | PubMed |
| 34445651 | The Role of Fc Receptors on the Effectiveness of Therapeutic Monoclonal Antibodies. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34445651 | PubMed |
| 31836861 | Therapies for rare diseases: therapeutic modalities, progress and challenges ahead. | Nat Rev Drug Discov | 2020 | https://conductscience.org/library/papers/31836861 | PubMed |
| 28733914 | Molecular and functional analysis of monoclonal antibodies in support of biologics development. | Protein Cell | 2018 | https://conductscience.org/library/papers/28733914 | PubMed |
| 26441475 | Therapeutic antibodies: their mechanisms of action and the pathological findings they induce in toxicity studies. | J Toxicol Pathol | 2015 | https://conductscience.org/library/papers/26441475 | PubMed |
| 25484230 | Optimization of the crystallizability of a single-chain antibody fragment. | Acta Crystallogr F Struct Biol Commun | 2014 | https://conductscience.org/library/papers/25484230 | PubMed |
| 23751612 | Characterization of a surrogate murine antibody to model anti-human CD3 therapies. | MAbs | 2013 | https://conductscience.org/library/papers/23751612 | PubMed |
| 22939368 | The road to purified hematopoietic stem cell transplants is paved with antibodies. | Curr Opin Immunol | 2012 | https://conductscience.org/library/papers/22939368 | PubMed |
| 12529161 | Therapy for acute rejection in pediatric organ transplant recipients. | Paediatr Drugs | 2003 | https://conductscience.org/library/papers/12529161 | PubMed |
| 9246765 | Morphology of rat kidney and thymus after native and antibody-coupled cyclosporin A application (reduced toxicity of targeted drug). | Folia Microbiol (Praha) | 1997 | https://conductscience.org/library/papers/9246765 | PubMed |
| 8690455 | Sensitization of T-cell receptor-alpha beta+ T cells recovered from long-term T-cell receptor downmodulation. | Immunology | 1996 | https://conductscience.org/library/papers/8690455 | PubMed |
| 8439495 | Characterisation of a humanised bispecific monoclonal antibody for cancer therapy. | Br J Cancer | 1993 | https://conductscience.org/library/papers/8439495 | PubMed |
| 8251324 | New immunosuppressive agents for pediatric transplantation. | Pediatr Nephrol | 1993 | https://conductscience.org/library/papers/8251324 | PubMed |
| 8157269 | Inhibition of allograft rejection by anti-T-cell receptor-alpha beta monoclonal antibodies preserving resistance to bacterial infection. | Immunology | 1994 | https://conductscience.org/library/papers/8157269 | PubMed |
| 7680292 | Local immunosuppressive therapy with monoclonal anti-T cell antibody on renal allograft survival in the rat. | Clin Exp Immunol | 1993 | https://conductscience.org/library/papers/7680292 | PubMed |
| 2503348 | Muromonab CD3. A review of its pharmacology and therapeutic potential. | Drugs | 1989 | https://conductscience.org/library/papers/2503348 | PubMed |
| 1833167 | OKT3 prophylaxis in liver transplantation. | Dig Dis Sci | 1991 | https://conductscience.org/library/papers/1833167 | PubMed |
| 1753685 | Perspectives in transplantation immunology 1991. | Klin Wochenschr | 1991 | https://conductscience.org/library/papers/1753685 | PubMed |
| 1431256 | Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation. | J Infect Dis | 1992 | https://conductscience.org/library/papers/1431256 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3105134
GET https://conductscience.org/api/papers/v1/3105134/cited_by?page=2